Brian Dean

16.4k total citations · 1 hit paper
363 papers, 12.7k citations indexed

About

Brian Dean is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Brian Dean has authored 363 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 202 papers in Molecular Biology, 150 papers in Cellular and Molecular Neuroscience and 85 papers in Psychiatry and Mental health. Recurrent topics in Brian Dean's work include Neuroscience and Neuropharmacology Research (107 papers), Receptor Mechanisms and Signaling (104 papers) and Neurotransmitter Receptor Influence on Behavior (56 papers). Brian Dean is often cited by papers focused on Neuroscience and Neuropharmacology Research (107 papers), Receptor Mechanisms and Signaling (104 papers) and Neurotransmitter Receptor Influence on Behavior (56 papers). Brian Dean collaborates with scholars based in Australia, United States and United Kingdom. Brian Dean's co-authors include Elizabeth Scarr, David Copolov, Andrew S. Gibbons, Elizabeth A. Thomas, Madhara Udawela, Geoffrey Pavey, Suresh Sundram, Jeremy M. Crook, Kenneth Opeskin and Dahlia Keriakous and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Brian Dean

360 papers receiving 12.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

2010 932 citations Brian Dean et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Brian Dean	5.7k	4.6k	2.9k	2.2k	1.6k	363	12.7k
Nakao Iwata	3.3k 0.6×	3.0k 0.6×	3.0k 1.0×	1.3k 0.6×	2.1k 1.3×	482	11.4k
Thomas M. Hyde	6.3k 1.1×	3.9k 0.8×	2.5k 0.9×	1.2k 0.6×	3.0k 1.8×	258	15.0k
Masaomi Iyo	4.3k 0.8×	6.8k 1.5×	2.9k 1.0×	3.0k 1.4×	851 0.5×	405	15.3k
Dan Rujescu	3.1k 0.5×	2.2k 0.5×	2.6k 0.9×	1.6k 0.8×	2.2k 1.3×	347	11.4k
Robert H. Belmaker	2.7k 0.5×	3.1k 0.7×	4.5k 1.6×	1.4k 0.6×	1.6k 1.0×	291	13.0k
Hiroshi Kunugi	4.2k 0.7×	3.3k 0.7×	2.9k 1.0×	3.0k 1.4×	2.0k 1.2×	446	15.7k
Andrew J. Dwork	3.5k 0.6×	3.0k 0.7×	1.2k 0.4×	1.4k 0.6×	1.2k 0.7×	140	10.4k
Akira Sawa	10.8k 1.9×	5.2k 1.1×	2.3k 0.8×	2.7k 1.2×	2.5k 1.5×	325	20.4k
Bernard Lerer	2.8k 0.5×	2.9k 0.6×	4.3k 1.5×	1.4k 0.6×	2.6k 1.6×	339	12.6k
Gavin P. Reynolds	5.0k 0.9×	7.7k 1.7×	4.2k 1.5×	2.1k 1.0×	870 0.5×	329	16.7k

Countries citing papers authored by Brian Dean

Since Specialization

Citations

This map shows the geographic impact of Brian Dean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Dean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Dean more than expected).

Fields of papers citing papers by Brian Dean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Dean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Dean. The network helps show where Brian Dean may publish in the future.

Co-authorship network of co-authors of Brian Dean

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Dean. A scholar is included among the top collaborators of Brian Dean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Dean. Brian Dean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matosin, Natalie, Anna C. Koller, Franziska Degenhardt, et al.. (2025). Exon-variant interplay and multi-modal evidence identify endocrine dysregulation in severe psychiatric disorders impacting excitatory neurons. Translational Psychiatry. 15(1). 153–153. 1 indexed citations

Dean, Brian, et al.. (2024). Higher levels of AKT-interacting protein in the frontal pole from people with schizophrenia are limited to a sub-group who have a marked deficit in cortical muscarinic M1 receptors. Psychiatry Research. 341. 116156–116156. 1 indexed citations

Bron, Romke, Cameron J. Nowell, Catriona McLean, et al.. (2024). The distribution of Hypocretin/Orexin receptor mRNA in the mouse and human brain. SHILAP Revista de lepidopterología. 24. 100202–100202. 2 indexed citations

Rae, Caroline, Denny Meyer, Erica Neill, et al.. (2024). Glutamate concentrations and cognitive deficits in ultra-treatment-resistant schizophrenia: An exploratory and comparative 1H-MRS study. Psychiatry Research Neuroimaging. 347. 111926–111926. 1 indexed citations

Walker, Abigail, et al.. (2023). A universal surrogate matrix assay for urea measurement in clinical pharmacokinetic studies of respiratory diseases. Biomedical Chromatography. 37(10). e5713–e5713. 2 indexed citations

Dean, Brian, Vahram Haroutunian, & Elizabeth Scarr. (2023). Lower levels of cortical [3H]pirenzepine binding to postmortem tissue defines a sub-group of older people with schizophrenia with less severe cognitive deficits. Schizophrenia Research. 255. 274–282. 7 indexed citations

Dean, Brian. (2023). Muscarinic M1 and M4 receptor agonists for schizophrenia: promising candidates for the therapeutic arsenal. Expert Opinion on Investigational Drugs. 32(12). 1113–1121. 6 indexed citations

Gibbons, Andrew S., et al.. (2021). An investigation into nicotinic receptor involvement in mood disorders uncovers novel depression candidate genes. Journal of Affective Disorders. 288. 154–160. 2 indexed citations

Grace, Sally, et al.. (2020). The influence of COMT rs4680 on functional connectivity in healthy adults: A systematic review. European Journal of Neuroscience. 52(8). 3851–3878. 12 indexed citations

10.

Nakaya, Akihiro, Kayoko Esaki, Shabeesh Balan, et al.. (2020). Lipid Pathology of the Corpus Callosum in Schizophrenia and the Potential Role of Abnormal Gene Regulatory Networks with Reduced Microglial Marker Expression. Cerebral Cortex. 31(1). 448–462. 20 indexed citations

11.

Dean, Brian, Linh Q. Lam, Elizabeth Scarr, & James A. Duce. (2018). Cortical biometals: Changed levels in suicide and with mood disorders. Journal of Affective Disorders. 243. 539–544. 10 indexed citations

12.

Han, Laura K. M., Moji Aghajani, Shaunna L. Clark, et al.. (2018). Epigenetic Aging in Major Depressive Disorder. American Journal of Psychiatry. 175(8). 774–782. 171 indexed citations

13.

Udawela, Madhara, et al.. (2016). Allosteric modulation of cholinergic system: Potential approach to treating cognitive deficits of schizophrenia. Swinburne Research Bank (Swinburne University of Technology). 5(1). 32–32. 2 indexed citations

14.

Gaston, R. Glenn, Søren Erik Larsen, Gary M. Pess, et al.. (2015). The Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for 2 Dupuytren Contractures in the Same Hand: A Prospective, Multicenter Study. The Journal Of Hand Surgery. 40(10). 1963–1971. 48 indexed citations

15.

Gibbons, Andrew S., Won Je Jeon, Elizabeth Scarr, & Brian Dean. (2015). Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and Antidepressants. The International Journal of Neuropsychopharmacology. 19(4). pyv118–pyv118. 14 indexed citations

16.

Sánchez, Diego, et al.. (2009). Decreased kainate receptors in the hippocampus of apolipoprotein D knockout mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34(2). 271–278. 5 indexed citations

17.

Gray, Laura, Maarten van den Buuse, Elizabeth Scarr, Brian Dean, & Anthony J. Hannan. (2008). Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-d-aspartic acid receptor up-regulation. The International Journal of Neuropsychopharmacology. 12(1). 45–45. 106 indexed citations

18.

Sakai, Kazuo, et al.. (2000). Ionotropic Glutamate Receptors and Expression of N-Methyl-d-Aspartate Receptor Subunits in Subregions of Human Hippocampus: Effects of Schizophrenia. American Journal of Psychiatry. 157(7). 1141–1149. 297 indexed citations

19.

Dean, Brian, et al.. (1999). Increased frontal cortical GABA(A) receptors and decreased serotonin(2a) receptors in schizophrenia. Journal of Neurochemistry. 73. 2 indexed citations

20.

Bartley, W & Brian Dean. (1968). Extraction and estimation of glycogen and oligosaccharides from rat heart. Analytical Biochemistry. 25(1). 99–108. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact